Cornerstone National Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.8K Hold
1,500
0.01% 142
2026
Q1
$42.8K Hold
1,500
0.02% 127
2025
Q4
$37.4K Hold
1,500
0.01% 113
2025
Q3
$38.2K Hold
1,500
0.02% 110
2025
Q2
$36.4K Hold
1,500
0.02% 106
2025
Q1
$38K Hold
1,500
0.02% 101
2024
Q4
$39.8K Hold
1,500
0.02% 95
2024
Q3
$43.4K Buy
+1,500
New +$43.8K 0.02% 93
2021
Q1
Sell
-21,012
Closed -$773K 62
2020
Q4
$773K Buy
21,012
+221
+1% +$8.11K 0.42% 40
2020
Q3
$724K Sell
20,791
-296
-1% -$10.4K 0.46% 39
2020
Q2
$654K Sell
21,087
-5,825
-22% -$198K 0.48% 38
2020
Q1
$833K Buy
26,912
+9,360
+53% +$319K 0.75% 20
2019
Q4
$652K Buy
+17,552
New +$625K 0.58% 44

Other funds holding PFE

Cornerstone National Bank & Trust's PFE Position: Q2 2026 in Review

Cornerstone National Bank & Trust held its Pfizer (PFE) position steady in Q2 2026 at 1,500 shares worth $35.8K. The position accounts for 0.01% of the portfolio, ranked #142.

Cornerstone National Bank & Trust first reported a position in PFE in Q4 2019 and has held it in 13 quarters since. The position peaked at $833K in Q1 2020. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cornerstone National Bank & Trust held 1,500 shares of Pfizer worth $35.8K as of Q2 2026.
  • Cornerstone National Bank & Trust left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #142 holding.
  • Cornerstone National Bank & Trust first reported a position in Pfizer in Q4 2019 and has held it in 13 quarters since.
  • Cornerstone National Bank & Trust's Pfizer position peaked at $833K in Q1 2020.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.